feed,title,long_url,short_url
SeekingAlpha,Supreme Court rules against Amgen in Rapatha patent dispute with Sanofi/ Regeneron,https://seekingalpha.com/news/3973082,
SeekingAlpha,New Relic could see $88-$100 a share in potential takeover - analysts,https://seekingalpha.com/news/3973080,
